Tesla shares drop after third-quarter profit falls short of estimates
GeneDx Holdings (NASDAQ:WGS) Chief Financial Officer Kevin Feeley sold 3,728 shares of Class A Common Stock on September 16, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $121.4727, resulting in a total transaction value of approximately $452,850. The prices for the shares sold ranged from $118.28 to $123.07. The sale comes as GeneDx stock trades near its 52-week high of $136, having delivered an impressive 70% return year-to-date.
The transaction was to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (RSUs). Feeley also exercised options to acquire 7,197 shares of Class A Common Stock. According to InvestingPro, GeneDx has shown strong momentum with multiple positive indicators available to subscribers.
Following the sale, Feeley directly owns 8,755 shares of GeneDx Holdings, a company currently valued at $3.75 billion by market capitalization.
In other recent news, GeneDx reported strong second-quarter results, surpassing revenue expectations by more than $17 million, a 20% increase. The company also exceeded bottom-line forecasts by $15 million, leading BTIG to raise its price target from $100 to $125 while maintaining a Buy rating. Similarly, Piper Sandler increased its price target for GeneDx to $140 from $120, citing the company’s unique data assets and compelling growth prospects. Piper Sandler also reiterated its Overweight rating on the stock, highlighting the company’s multiyear growth potential.
In corporate governance developments, GeneDx expanded its board of directors with the appointment of Thomas Fuchs as a Class I director. Fuchs, who is the Chief AI Officer at Eli Lilly, brings extensive experience in artificial intelligence, having previously held roles at Mount Sinai and other prestigious institutions. These recent developments reflect GeneDx’s ongoing strategic initiatives and positive financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.